Rationale and design of a randomised controlled trial evaluating the effectiveness of an exercise program to improve the quality of life of patients with heart failure in primary care: The EFICAR study protocol.

BMC Public Health
Ana ZuazagoitiaEFICAR Group (Ejercicio Físico en la Insuficiencia Cardiaca)

Abstract

Quality of life (QoL) decreases as heart failure worsens, which is one of the greatest worries of these patients. Physical exercise has been shown to be safe for people with heart failure. Previous studies have tested heterogeneous exercise programs using different QoL instruments and reported inconsistent effects on QoL. The aim of this study is to evaluate the effectiveness of a new exercise program for people with heart failure (EFICAR), additional to the recommended optimal treatment in primary care, to improve QoL, functional capacity and control of cardiovascular risk factors. Multicenter clinical trial in which 600 patients with heart failure in NYHA class II-IV will be randomized to two parallel groups: EFICAR and control. After being recruited, through the reference cardiology services, in six health centres from the Spanish Primary Care Prevention and Health Promotion Research Network (redIAPP), patients are followed for 1 year after the beginning of the intervention. Both groups receive the optimized treatment according to the European Society of Cardiology guidelines. In addition, the EFICAR group performs a 3 month supervised progressive exercise program with an aerobic (high-intensity intervals) and a strength com...Continue Reading

Associated Clinical Trials

References

Jan 5, 2002·The New England Journal of Medicine·J N CohnUNKNOWN Valsartan Heart Failure Trial Investigators
Jul 2, 2002·American Journal of Respiratory and Critical Care Medicine·UNKNOWN ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories
Oct 3, 2002·Circulation·Raymond J GibbonsUNKNOWN American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Ex
Mar 5, 2003·Circulation·Ileana L PiñaUNKNOWN American Heart Association Committee on exercise, rehabilitation, and prevention
May 12, 2004·Heart & Lung : the Journal of Critical Care·Eileen CollinsLonnie Edwards
Jul 22, 2004·The Cochrane Database of Systematic Reviews·K ReesS Ebrahim
Dec 17, 2004·Journal of Cardiopulmonary Rehabilitation·Timothy R McConnell
Dec 13, 2005·Current Opinion in Nephrology and Hypertension·Marc A Silver
Feb 17, 2006·Current Opinion in Nephrology and Hypertension·Claudine JurkovitzWilliam M McClellan
Jan 24, 2007·American Heart Journal·David J WhellanUNKNOWN HF-ACTION Trial Investigators
Oct 13, 2007·Heart Failure Reviews·Randy W Braith, Darren T Beck
Nov 8, 2007·Medicine and Science in Sports and Exercise·Patrick FeiereisenJean Beissel
Mar 26, 2008·Revista española de cardiología·Olatz GarinUNKNOWN Grupo IC-QoL
Oct 23, 2008·The American Journal of Cardiology·Birgitta Blakstad NilssonMay Arna Risberg
Apr 9, 2009·JAMA : the Journal of the American Medical Association·Christopher M O'ConnorUNKNOWN HF-ACTION Investigators
Apr 9, 2009·JAMA : the Journal of the American Medical Association·Kathryn E FlynnUNKNOWN HF-ACTION Investigators

❮ Previous
Next ❯

Software Mentioned

EFICAR
SAS
Action
HF

Related Concepts

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.